The GOP-led House Oversight Committee has not yet discussed investigating the timing of former President Joe Biden’s prostate cancer diagnosis, Committee Chairman James Comer (R., Ky.) told National Review in a brief interview on Tuesday, emphasizing that the committee’s current focus is on the former president’s use of autopen to sign executive orders.
“Our concern is who was running the White House, who was operating the autopen, and did Joe Biden authorize his signature to be used so many times in the last 90 days,” he said, adding that the committee hasn’t “talked about” investigating the timing of the former president’s recent diagnosis.
Comments